Epigenetic Testing for Male Fertility Management
Larry I. Lipshultz, MD, discusses epigenetic testing for male fertility management and the treatment implications for men with infertility.
Read MoreSelect Page
Larry I. Lipshultz, MD, is Professor of Urology and Chief of the Scott Department of Urology’s Division of Male Reproductive Medicine and Surgery at Baylor College of Medicine in Houston, Texas. Dr. Lipshultz, who holds the Smith Chair in Reproductive Medicine, is a well-known authority on abnormalities of male reproduction, erectile dysfunction, and male hormone therapy. He has published more than 390 journal articles and has instituted a fellowship training program in male reproductive medicine and surgery that has trained more than 80 physicians who are now in practice both here and abroad.
Dr. Lipshultz received his MD from the University of Pennsylvania in Philadelphia and completed a fellowship at the University of Texas at Houston as the first AUA research scholar. His professional interests include vasectomies and their reversal, male infertility, in vitro fertilization, erectile dysfunction, low testosterone, Peyronie’s disease, and sexual wellness. He is a member of numerous medical organizations, including the American Society for Reproductive Medicine (of which he is also a former president), the American Society of Andrology, the Houston Reproductive Society, and the Houston Urological Society.
Posted by Larry I. Lipshultz, MD | Mar 2023
Larry I. Lipshultz, MD, discusses epigenetic testing for male fertility management and the treatment implications for men with infertility.
Read MorePosted by Larry I. Lipshultz, MD | Nov 2020
Larry I. Lipshultz, MD, Professor of Urology and Chief of the Scott Department of Urology’s Division of Male Reproductive Medicine and Surgery at Baylor College of Medicine in Houston, Texas, discusses the often overlooked detrimental impact of environmental toxins on male reproductive health. He begins with a brief overview of the history of these damaging toxicants and notes that it was not until the early 90’s that a link was drawn between them and male reproductive health. Dr. Lipshultz then explores the toxicant classifications, dividing them into four main categories: Endocrine Disrupting Chemicals (EDCs), chemicals that have diverse actions that impair cellular function, chemicals that cause cancer, and toxins that can relay isolated and severe testicular damage. He summarizes each toxicant grouping and discusses why they are harmful. Noting that there is a debate in the scientific community between the impact of genetics and the environmental impact as it relates to testicular cancer, Dr. Lipshultz cites several important studies that have found direct links between exposure to the toxicants and increased risk for developing testicular cancer. Dr. Lipshultz then details four specific toxicants and their potential for damage: BPAs, Phthalates, Glycol ethers (solvents), and DBCP (pesticides). He explains what they are, where they are found, how they work, and their detrimental effects on male reproductive organs. In conclusion, Dr. Lipshultz reviews the results of a number of studies about these toxicants, adding that many government agencies, retailers, and manufacturers are taking steps to monitor and decrease their harmful effects.
Read MorePosted by Larry I. Lipshultz, MD | Nov 2018
Larry I. Lipshultz, MD, discusses the frequency of renal failure and kidney transplants, as well as fertility and hormone differences in patients pre- and post-renal transplant. He then reviews drugs used to prevent organ rejection and the potential impact these drugs can have on offspring.
Read MorePosted by Larry I. Lipshultz, MD | Oct 2018
Larry I. Lipshultz, MD, provides an up-to-date definition of gender dysphoria and criteria for urologic transgender surgery. He also shares an interview with a patient prior to surgery and a review, in movie format, of an actual operative procedure.
Read More